Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study
- PMID: 32979574
- PMCID: PMC7510771
- DOI: 10.1016/j.cmi.2020.09.023
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study
Abstract
Objectives: To describe the prevalence, nature and risk factors for the main clinical sequelae in coronavirus disease 2019 (COVID-19) survivors who have been discharged from the hospital for more than 3 months.
Methods: This longitudinal study was based on a telephone follow-up survey of COVID-19 patients hospitalized and discharged from Renmin Hospital of Wuhan University, Wuhan, China before 1 March 2020. Demographic and clinical characteristics and self-reported clinical sequelae of the survivors were described and analysed. A cohort of volunteers who were free of COVID-19 and lived in the urban area of Wuhan during the outbreak were also selected as the comparison group.
Results: Among 538 survivors (293, 54.5% female), the median (interquartile range) age was 52.0 (41.0-62.0) years, and the time from discharge from hospital to first follow-up was 97.0 (95.0-102.0) days. Clinical sequelae were common, including general symptoms (n = 267, 49.6%), respiratory symptoms (n = 210, 39%), cardiovascular-related symptoms (n = 70, 13%), psychosocial symptoms (n = 122, 22.7%) and alopecia (n = 154, 28.6%). We found that physical decline/fatigue (p < 0.01), postactivity polypnoea (p= 0.04) and alopecia (p < 0.01) were more common in female than in male subjects. Dyspnoea during hospitalization was associated with subsequent physical decline/fatigue, postactivity polypnoea and resting heart rate increases but not specifically with alopecia. A history of asthma during hospitalization was associated with subsequent postactivity polypnoea sequela. A history of pulse ≥90 bpm during hospitalization was associated with resting heart rate increase in convalescence. The duration of virus shedding after COVID-19 onset and hospital length of stay were longer in survivors with physical decline/fatigue or postactivity polypnoea than in those without.
Conclusions: Clinical sequelae during early COVID-19 convalescence were common; some of these sequelae might be related to gender, age and clinical characteristics during hospitalization.
Keywords: COVID-19; Clinical sequelae; Early recovery; SARS-CoV-2; Survivors.
Copyright © 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, China.JAMA Netw Open. 2021 Sep 1;4(9):e2127403. doi: 10.1001/jamanetworkopen.2021.27403. JAMA Netw Open. 2021. PMID: 34586367 Free PMC article.
-
Some characteristics of clinical sequelae of COVID-19 survivors from Wuhan, China: A multi-center longitudinal study.Influenza Other Respir Viruses. 2022 May;16(3):395-401. doi: 10.1111/irv.12943. Epub 2021 Nov 19. Influenza Other Respir Viruses. 2022. PMID: 34796652 Free PMC article.
-
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.Lancet. 2021 Jan 16;397(10270):220-232. doi: 10.1016/S0140-6736(20)32656-8. Epub 2021 Jan 8. Lancet. 2021. Retracted and republished in: Lancet. 2023 Jun 17;401(10393):2025. doi: 10.1016/S0140-6736(23)01175-3. PMID: 33428867 Free PMC article. Retracted and republished.
-
Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.Chron Respir Dis. 2021 Jan-Dec;18:14799731211002240. doi: 10.1177/14799731211002240. Chron Respir Dis. 2021. PMID: 33729021 Free PMC article.
-
Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis.Infection. 2022 Oct;50(5):1067-1109. doi: 10.1007/s15010-022-01862-3. Epub 2022 Jun 24. Infection. 2022. PMID: 35750943 Free PMC article.
Cited by
-
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.JAMA. 2022 Oct 25;328(16):1604-1615. doi: 10.1001/jama.2022.18931. JAMA. 2022. PMID: 36215063 Free PMC article.
-
Long COVID in children and adolescents: a historical cohort study with a population-based control group from Iran.BMC Infect Dis. 2024 Sep 30;24(1):1074. doi: 10.1186/s12879-024-09997-4. BMC Infect Dis. 2024. PMID: 39350082 Free PMC article.
-
Long term predictors of breathlessness, exercise intolerance, chronic fatigue and well-being in hospitalized patients with COVID-19: A cohort study with 4 months median follow-up.J Infect Public Health. 2022 Jan;15(1):21-28. doi: 10.1016/j.jiph.2021.11.016. Epub 2021 Nov 18. J Infect Public Health. 2022. PMID: 34861604 Free PMC article.
-
Prevalence and risk factors for postinfectious cough in discharged patients with coronavirus disease 2019 (COVID-19).J Thorac Dis. 2022 Jun;14(6):2079-2088. doi: 10.21037/jtd-21-876. J Thorac Dis. 2022. PMID: 35813767 Free PMC article.
-
What might COVID-19 patients experience after recovery? A comprehensive review.Int J Pharm Pract. 2022 Nov 4;30(5):404-413. doi: 10.1093/ijpp/riac026. Int J Pharm Pract. 2022. PMID: 35881153 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous